Home›Companies›Healthcare›Dynocardia

Dynocardia, Inc.

Updated Oct 27, 2026·Latest SEC filing Dec 12, 2025·Suggest an edit

About Dynocardia

Dynocardia is a private company based in Newton Center, Massachusetts. It has reported $8,489,890 raised in four offerings on Form D since May 2019. Its chief executive is Mohan Thanikachalam.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Mar 4, 2025Mar 14, 2025amended Dec 12, 2025$1,240,638of $2.0M target20$62,032EquityRule 506(b)Form D/A ↗1 earlier filing
Mar 24, 2023Apr 3, 2023amended Dec 12, 2025$4,759,253of $6.0M target47$101KEquityRule 506(b)Form D/A ↗4 earlier filings
Jan 31, 2020Feb 14, 2020amended Jan 21, 2021$2,000,000of $2.5M target19$105KDebtRule 506(b)Form D/A ↗2 earlier filings
Apr 29, 2019May 13, 2019amended Oct 30, 2020$489,999of $500K target7$70,000DebtRule 506(b)Form D/A ↗1 earlier filing
Total, four offerings$8,489,890

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Dynocardia's Form D filed Dec 12, 2025.

MT
Mohan Thanikachalam
President and CEO, director

Sources

  1. SECDynocardia, Inc. Form D/A, filed Mar 20, 2025
  2. SECDynocardia, Inc. Form D, filed Mar 14, 2025
  3. SECDynocardia, Inc. Form D/A, filed Jan 6, 2025
  4. SECDynocardia, Inc. Form D/A, filed Apr 4, 2024
  5. SECDynocardia, Inc. Form D, filed Apr 3, 2023
  6. SECDynocardia, Inc. Form D/A, filed Oct 30, 2020
  7. SECDynocardia, Inc. Form D, filed Feb 14, 2020
  8. SECDynocardia, Inc. Form D, filed May 13, 2019
  9. SECDynocardia, Inc. filing history